- NEWS FEATURE
Heart disease after COVID: what the data say
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 608, 26-28 (2022)
doi: https://doi.org/10.1038/d41586-022-02074-3
References
Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Nature Med. 28, 583–590 (2022).
Xie, Y. & Al-Aly, Z. Lancet Diabetes Endocrinol. 10, 311–321 (2022).
Bazdyrev, E. et al. Pharmaceuticals 14, 807 (2021).
Boldrini, M., Canoll, P. D. & Klein, R. S. JAMA Psychiatry 78, 682–683 (2021).
Ayoubkhani, D. et al. BMJ 372, n693 (2021).
Daugherty, S. E. et al. BMJ 373, n1098 (2021).
Singh, T. et al. Heart 108, 46–53 (2022).
Expert Consensus Decision Pathway. J. Am. Coll. Cardiol. 79, 1717–1756 (2022).
The PHOSP-COVID Collaborative Group. Lancet Respir. Med. 10, 761–775 (2022).
Taquet, M., Husain, M., Geddes, J. R., Luciano, S. & Harrison, P. J. eClinicalMedicine 39, 101061 (2021).
Wang, E. Y. et al. Nature 595, 283–288 (2021).
Al-Aly, Z., Bowe, B. & Xie, Y. Nature Med. 28, 1461–1467 (2022).